At present BNP and NT-proBNP are established diagnostic biomarkers for heart failure (105, 106), ventricular remodelling after acute myocardial infarction (96, 107), left ventricular hypertrophy (103, 108) and pulmonary hypertension (109). This evidence concerns the gene NPPB and pulmonary hypertension.